Search clinical trials for: malic acid

Total 24150 results

Hams Hamed Abdelrahman

Recruiting

Malic Acid in Treatment of Xerostomia

Xerostomia

Egypt
Universidad de Granada
Instituto de Salud Carlos III

Completed

Drug-induced Xerostomia. Evaluation of Malic Acid 1%, Salivary Mucins and Buffering Capacity

Depression | Hypertension | Xerostomia

Spain
Beijing Chest Hospital
Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

A Real-World Study of Pyrotinib Maleate in the Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer With Rare Mutations in HER2

HER2 Mutant Non-small Cell Lung Cancer
Teligene US

Recruiting

A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC

Non-small Cell Lung Cancer

United States
IlDong Pharmaceutical Co Ltd

Unknown

Pharmacokinetics of Besifovir in Adults With Normal and Impaired Renal Function

Renal Impairment
Teligene US

Recruiting

Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

United States
Nerre Therapeutics Ltd.
Pharm-Olam International

Active, not recruiting

Efficacy and Safety Study of Orvepitant for Chronic Cough in Patients With Idiopathic Pulmonary Fibrosis (IPF-COMFORT)

Cough | Idiopathic Pulmonary Fibrosis

United States, United Kingdom, Netherlands
Tiziana Life Sciences LTD

Terminated

Study Of Oral PHA-848125AC In Patients With Malignant Thymoma Previously Treated With Multiple Lines Of Chemotherapy

Malignant Thymoma

United States, Italy
Tiziana Life Sciences LTD

Terminated

Phase II Study Of Oral PHA-848125AC In Patients With Thymic Carcinoma

Thymic Carcinoma

United States, France, Italy
Nerre Therapeutics Ltd.

Completed

A Dose-ranging Study of Orvepitant in Patients With Chronic Refractory Cough

Chronic Refractory Cough

United States, Canada, United Kingdom
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Fudan University

Unknown

A Phase I Study of Subutinib Maleate Capsules on Toleration and Pharmacokinetics

Solid Tumor

China
Stony Brook University

Unknown

Magic Therapy to Relieve Pediatric Patient Anxiety and Improve the Hospitalization Experience

Anxiety

United States
Zhongshan Hospital Xiamen University

Not yet recruiting

An Exploratory Basket Study of Pyrotinib Maleate Tablets in HER2 Mutated or Amplified of Metastatic Solid Tumors

Solid Tumor
Merck Sharp & Dohme LLC

Completed

Vicriviroc (SCH 417690) Treatment Protocol in Human Immunodeficiency Virus (HIV)-Infected Participants: A Rollover Study for ACTG Protocol A5211 (P04100)

HIV Infections | HIV
Stereotaxis
Osypka AG

Recruiting

The MAGiC™ Cardiac Ablation European Study (MAGiC-FEST)

Arrhythmias, Cardiac

Denmark, Lithuania
University of Minnesota

Completed

Mobile Phone Technology to Increase Genetic Counseling (mAGIC)

Ovarian Cancer

United States
Tiziana Life Sciences LTD

Completed

Study of Milciclib in Patients With Unresectable/Metastatic Hepatocellular Carcinoma

Hepatocellular Carcinoma

Israel, Greece, Italy
Eisai Inc.

Completed

A Open-label, Three-period, Partial-replicate Design Study to Evaluate the Inter- and Intrasubject Variability of the Avatrombopag To-be-marketed Formulation Administered as Single Doses of 40 mg to Healthy Subjects Receiving a Low-fat Meal

Healthy Volunteers

United States
Shanghai Mental Health Center
Jiangsu Kanion Pharmaceutical Co.

Unknown

Tolerance, PK and PD Effects Study of TPN-672 in Chinese Healthy Volunteers

PHA1A

China
Photocure

Completed

Photodynamic Therapy (PDT) With Methyl Aminolevulinate (MAL) Cream in Moderate to Severe Acne

Acne Vulgaris

United States
Novartis

Completed

Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) in Chronic Obstructive Pulmonary Disease (COPD)

Lung Diseases, Obstructive | Pulmonary Disease, Chronic Obstructive | COPD

Belgium
The First Affiliated Hospital with Nanjing Medical...
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

Pyrotinib in Women With High-risk in Early Stage Breast Cancer

HER2-positive Breast Cancer

China
The First Affiliated Hospital of Zhengzhou University
BeiGene; Jiangsu Hengrui Pharmaceutical Co., Ltd.; RemeGen Co., Ltd.

Not yet recruiting

Study of Tislelizumab Combined With DisitamabVedotin and Pyrotinib Maleate in HER2-positive or Mutated Advanced Colorectal Cancer Who Failed Standard Therapy

HER2-positive or Mutated Advanced Colorectal Cancer
Novartis

Completed

Efficacy and Safety of Single Doses of Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) Compared to Placebo in Patients With Persistent Asthma

Asthma

United States
Instituto Palacios
eCareYou Innovation

Completed

Pilot Study for the Urinary Incontinence Treatment

Urinary Incontinence

Spain
Technical University of Munich

Completed

Marathon, Genetics, Inflammation and the Cardiovascular System: MAGIC-Trial (MAGIC)

Heart Failure | Sudden Cardiac Death

Germany
Hanny Al-Samkari, MD
Swedish Orphan Biovitrum

Recruiting

Avatrombopag vs. Placebo for CIT in GI Malignancies (ACT-GI)

Gastrointestinal Neoplasms | Gastrointestinal Cancer | Chemotherapy-Induced Thrombocytopenia

United States
Millennium Pharmaceuticals, Inc.

Completed

A Study to Evaluate the Efficacy and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic Gastroparesis

Diabetic Gastroparesis | Idiopathic Gastroparesis

United States, Belgium, Japan, Poland
University of Alabama at Birmingham

Recruiting

The Impact of a Virtual Magic Trick Training Program

Autism | Pervasive Developmental Disorder

United States
University of Alabama at Birmingham

Completed

Magic Camp for Children With Hemiplegic Cerebral Palsy

Cerebral Palsy

United States
Yaffa Golan, Ltd.

Completed

Open-label Pilot Study to Assess the Use of Magic Foot™ in the Improvment of Parameters in Subject With Foot Symptoms (MF)

Diabetes | Peripheral Vascular Disease

Israel
Wuhan University

Not yet recruiting

Exploratory Study of Neoadjuvant Treatment of HER2-positive Breast Cancer With Py in Combination With HP

Breast Cancer
LG Life Sciences

Completed

Bioequivalence of LB80380 Free Base and Maleate Salt Tablets

Hepatitis B

Korea, Republic of
Jiangsu Kanion Pharmaceutical Co., Ltd
Shanghai Mental Health Center

Not yet recruiting

Evaluate the Safety, Tolerability and Pharmacokinetic Profile of TPN672 Tablets Maleate in Patients With Schizophrenia (TPN672)

Schizophrenia

China
Fujian Medical University

Not yet recruiting

A Study to Evaluate Inetetamab + Pyrotinib + Chemotherapy in Previously Untreated HER2-Positive Metastatic Breast Cancer

HER2-positive Recurrent/Metastatic Breast Cancer
Novartis

Completed

Tolerability of Indacaterol Salts (Maleate, Xinafoate and Acetate) in Comparison to Placebo in Patients With Mild to Moderate Persistent Asthma

Asthma

Canada
Novartis Pharmaceuticals

Completed

Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.

Asthma

United States
Merck Sharp & Dohme LLC

Completed

Effect of Vicriviroc on HIV Ribonucleic Acid (RNA) Levels in Cerebrospinal Fluid (Study P05241)

HIV Infections
University of Ulster
Western Health and Social Care Trust; Southern Health and Social Care Trust; Tech... and other collaborators

Unknown

Magic Glass Evaluation in People With Stroke

Stroke

Italy, United Kingdom
University Clinical Research Center, Mali
Columbia University; Fogarty International Center of the National Institute...

Completed

Potential Effectiveness of the Diabetes Prevention Program in the Peri-urban Area of Bamako, Mali (PPD-Mali)

Diabetes Mellitus, Type 2

Mali
Chinese PLA General Hospital

Recruiting

Efficacy of Avatrombopag in Thrombocytopenic Patients With Chronic Liver Disease Undergoing an Elective Procedure

Chronic Liver Disease | Thrombocytopenia; Drugs

China
University of Milan
Fondazione Salvatore Maugeri

Completed

Effect of Indacaterol Maleate in Chronic Obstructive Pulmonary Disease (COPD) on Lung Volume and Related Dyspnea

Lung Diseases | Tachycardia | COPD | Dyspnea | Hypoxemia

Italy
National Cancer Institute (NCI)

Completed

AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors

Recurrent Childhood Medulloblastoma | Recurrent Childhood Ependymoma | Childhood Atypical Teratoid/Rhabdoid Tumor | Childhood Grade I Meningioma | Childhood Grade II Meningioma | Childhood Grade III Meningioma | Childhood Infratentorial Ependymoma | Childhood Supratentorial Ependymoma | Recurrent Childhood... and other conditions

United States
Icahn School of Medicine at Mount Sinai
National Institute of Mental Health (NIMH)

Recruiting

Connectomic Deep Brain Stimulation for Obsessive Compulsive Disorder

Obsessive Compulsive Disorder (OCD)

United States
IlDong Pharmaceutical Co Ltd

Completed

Bioequivalence Study to Compare the Pharmacokinetics of Besifovir in Healthy Adult Volunteers

Chronic Hepatitis B
Wayne State University

Withdrawn

Magic Shave Powder Gold's Affects on the Occurrence of Pseudofolliculitis Barbae

Pseudofolliculitis Barbae

United States
National Cancer Institute (NCI)

Terminated

AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine

Neurofibromatosis Type 1 | Plexiform Neurofibroma | Spinal Cord Neurofibroma

United States
Lithuanian University of Health Sciences
Merck Sharp & Dohme LLC; Indiana University School of Medicine

Completed

Intraocular Pressure, Blood Pressure, Ocular Perfusion and Blood Flow Fluctuations in Glaucoma Patients

Open Angle Glaucoma

Lithuania
Novartis

Completed

A Study of Three Doses of TCH346 in Patients With Early Parkinson's Disease to Evaluate Safety and Efficacy

Parkinson's Disease

United States, France, Germany, Portugal, Netherlands, United Kingdom, Italy, Canada, Brazil
Shenzhen Ausa Pharmed Co.,Ltd
Anhui Medical University

Completed

China Stroke Primary Prevention Trial (CSPPT)

Primary Hypertension

China

Search clinical trials for: malic acid

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Iran

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations